Community-based DOT-HAART accompaniment in an urban resource-poor setting

AIDS and Behavior

Volumn 14, Issue 3, 2010, Pages 721-730

  Muñoz, Maribel ^a   Finnegan, Karen ^b   Zeladita, Jhon ^a   Caldas, Adolfo ^c   Sanchez, Eduardo ^d   Callacna, Miriam ^d   Rojas, Christian ^d   Arevalo, Jorge ^e   Sebastian, Jose Luis ^f   Bonilla, Cesar ^f   Bayona, Jaime ^a   Shin, Sonya ^a,c,g  

^a SOCIOS EN SALUD   (Peru)

^b EMORY UNIVERSITY   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d Hospital Nacional Hipólito Unanue   (Peru)

^e HOSPITAL NACIONAL DOS DE MAYO   (Peru)

^f MINISTERIO DE SALUD   (Peru)

^g HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Adherence; DOT HAART; HIV; Poverty; Resource poor setting

Indexed keywords

ADULT; AIDS RELATED COMPLEX; ARTICLE; CASE CONTROL STUDY; COMMUNITY CARE; DIRECTLY OBSERVED THERAPY; DRUG COMBINATION; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PERU; POVERTY; PSYCHOLOGY; SOCIAL SUPPORT; TREATMENT OUTCOME; TUBERCULOSIS; URBAN POPULATION;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CASE-CONTROL STUDIES; COMMUNITY HEALTH SERVICES; DIRECTLY OBSERVED THERAPY; DRUG THERAPY, COMBINATION; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; PERU; POVERTY; PSYCHOLOGY; SOCIAL SUPPORT; TREATMENT OUTCOME; TUBERCULOSIS; URBAN POPULATION; YOUNG ADULT;

EID: 77956885713     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10461-009-9559-5     Document Type: Article

References (46)

1. Bangsberg D. R., Hecht F. M., Charlebois E. D., Zolopa A. R., Holodniy M., Sheiner L., et al. (2000). Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS (London, England) 14 (4), 357-366. doi:10.1097/00002030-200003100-00008. (Pubitemid 30182431)
2. Behforouz, H. L., Kalmus, A., Scherz, C. S., Kahn, J. S., Kadakia, M. B., & Farmer, P. E. (2004). Directly observed therapy for HIV antiretroviral therapy in an urban US setting. Journal of Acquired Immune Deficiency Syndromes, 36(1), 642-645. doi: 10.1097/00126334-200405010-00016. (Pubitemid 38544517)
3. Berger, B. E., Ferrans, C. E., & Lashley, F. R. (2001). Measuring stigma in people with HIV: Psychometric assessment of the HIV stigma scale. Research in Nursing & Health, 24(6), 518-529. doi:10.1002/nur.10011. (Pubitemid 33604361)
4. Bisson, G. P., Gaolathe, T., Gross, R., Rollins, C., Bellamy, S., Mogorosi, M., et al. (2008). Overestimates of survival after HAART: Implications for global scale-up efforts. PLoS ONE, 3(3), e1725.
5. Bradley-Ewing, A., Thomson, D., Pinkston, M., & Goggin, K. J. (2008). A qualitative examination of the indirect effects of modified directly observed therapy on health behaviors other than adherence. AIDS Patient Care and STDs, 22(8), 663-668. doi:10.1089/apc.2007.0190.
6. Broadhead, W. E., Gehlbach, S. H., de Gruy, F. V., & Kaplan, B. H. (1988). The Duke-UNC functional social support questionnaire. Measurement of social support in family medicine patients. Medical Care, 26(7), 709-723. doi:10.1097/00005650-1988 07000-00006.
7. Bronfenbrenner, U. (1979). The ecology of human development: Experiments by nature and design. Cambridge: Harvard University Press.
8. Bukusuba, J., Kikafunda, J. K., & Whitehead, R. G. (2007). Food security status in households of people living with HIV/AIDS (PLWHA) in a Ugandan urban setting. The British Journal of Nutrition, 98(1), 211-217. doi:10.1017/S0007114507691806. (Pubitemid 47272167)
9. Byakika-Tusiime, J., Oyugi, J. H., Tumwikirize, W. A., Katabira, E. T., Mugyenyi, P. N., & Bangsberg, D. R. (2003). Ability to purchase and secure stable therapy are significant predictors of non-adherence to antiretroviral therapy in Kampala, Uganda. Presented February 10-14, 2003 at the 10th Conference on Retrovi-ruses and Opportunistic Infections (CROI), Boston, MA. Abstract #170 retrieved from http://www.retroconference.org/2003/ cd/Abstract/170.htm.
10. Castro, A. (2005). Adherence to antiretroviral therapy: Merging the clinical and social course of AIDS. PLoS Medicine, 2(12), e338. doi:10.1371/journal.pmed.0020338. (Pubitemid 43020976)
11. Castro, A., & Farmer, P. (2005). Understanding and addressing AIDS-related stigma: From anthropological theory to clinical practice in Haiti. American Journal of Public Health, 95(1), 53-59. doi: 10.2105/AJPH.2003.028563. (Pubitemid 40075882)
12. Chen, S. C., Yu, J. K., Harries, A. D., Bong, C. N., Kolola-Dzimadzi, R., Tok, T. S., King, C. C., & Wang, J. D. (2008). Increased mortality of male adults with AIDS related to poor compliance to antiretroviral therapy in Malawi. Tropical Medicine & International Health. doi: 10.1111/j.1365-3165.2008. 02029.x.
13. Chesney, M. A., Ickovics, J. R., Chambers, D. B., Gifford, A. L., Neidig, J., Zwickl, B., et al. (2000). Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments. Patient care committee & adherence working group of the outcomes committee of the adult AIDS clinical trials group (AACTG). AIDS Care, 12(3), 255-266. doi:10.1080/09540120050042891.
14. Derogatis, L. R., Lipman, R. S., Rickels, K., Uhlenhuth, E. H., & Covi, L. (1974). The hopkins symptom checklist (HSCL): A self-report symptom inventory. Behavioral Science, 19(1), 1-15. doi:10.1002/bs.3830190102.
15. Farmer, P., Leandre, F., Mukherjee, J. S., Claude, M., Nevil, P., Smith-Fawzi, M. C., et al. (2001). Community-based approaches to HIV treatment in resource-poor settings. Lancet, 358(9279), 404-409. doi:10.1016/S0140- 6736(01)05550-7. (Pubitemid 32739107)
16. Gill, C. J., Hamer, D. H., Simon, J. L., Thea, D. M., & Sabin, L. L. (2005). No room for complacency about adherence to antiret-roviral therapy in sub-Saharan Africa. AIDS (London, England), 19(12), 1243-1249. doi:10.1097/01.aids.0000180094.04652.3b.
17. Hardon, A. P., Akurut, D., Comoro, C., Ekezie, C., Irunde, H. F., Gerrits, T., et al. (2007). Hunger, waiting time and transport costs: Time to confront challenges to ART adherence in Africa. AIDS Care, 19(5), 658-665. doi:10.1080/09540120701244943. (Pubitemid 46763738)
18. Idoko, J. A., Agbaji, O., Agaba, P., Akolo, C., Inuwa, B., Hassan, Z., et al. (2007). Direct observation therapy-highly active antiretroviral therapy in a resource-limited setting: The use of community treatment support can be effective. International Journal of STD & AIDS, 18(11), 760-763. doi:10.1258/ 095646207782212252. (Pubitemid 351738881)
19. Kadiyala, S., & Gillespie, S. (2004). Rethinking food aid to fight AIDS. Food and Nutrition Bulletin, 25(3), 271-282.
20. Koenig, S. P., Leandre, F., & Farmer, P. E. (2004). Scaling-up HIV treatment programmes in resource-limited settings: The rural Haiti experience. AIDS (London, England), 18(Suppl. 3), S21-S25. doi:10.1097/00002030-200406003- 00005. (Pubitemid 39037455)
21. Larsson, E. C., Okong, P., Thorson, A., & Ekstrom, A. M. (2007). Antiretroviral treatment of HIV in Uganda: A comparison of three different delivery models in a single hospital. Transactions of the Royal Society of Tropical Medicine and Hygiene, 101(9), 885-892. doi:10.1016/j.trstmh.2007.04. 024. (Pubitemid 47108144)
22. Liechty, C. A., & Bangsberg, D. R. (2003). Doubts about DOT: Antiretroviral therapy for resource-poor countries. AIDS (London, England), 17(9), 1383-1387. doi:10.1097/00002030-200306130-00013. (Pubitemid 36819853)
23. Mills, E. J., Nachega, J. B., Buchan, I., Orbinski, J., Attaran, A., Singh, S., et al. (2006). Adherence to antiretroviral therapy in sub-Saharan Africa and North America: A meta-analysis. Journal of the American Medical Association, 296(6), 679-690. doi:10.1001/jama.296.6.679. (Pubitemid 44200639)
24. Mukherjee, J. S., Ivers, L., Leandre, F., Farmer, P., & Behforouz, H. (2006). Antiretroviral therapy in resource-poor settings: Decreasing barriers to access and promoting adherence. Journal of Acquired Immune Deficiency Syndromes, 43(Suppl. 1), S123-S126. doi:10.1097/01.qai.0000248348.25630.74. (Pubitemid 44885651)
25. Muyingo, S. K., Walker, A. S., Reid, A., Munderi, P., Gibb, D. M., Ssali, F., et al. (2008). Patterns of individual and population-level adherence to antiretroviral therapy and risk factors for poor adherence in the first year of the DART trial in Uganda and Zimbabwe. Journal of Acquired Immune Deficiency Syndromes, 48(4), 468-475.
26. Nachega, J. B., Knowlton, A. R., Deluca, A., Schoeman, J. H., Watkinson, L., Efron, A., et al. (2006). Treatment supporter to improve adherence to antiretroviral therapy in HIV-infected South African adults. A qualitative study. Journal of Acquired Immune Deficiency Syndromes, 43(Suppl. 1), S127-S133. doi: 10.1097/01.qai.0000248349.25630.3d. (Pubitemid 44885652)
27. Partners In Health. (2008). Partners in health 2008 annual report. Available from http://www.pih.org/inforesources/annual/PIH2008-annual report.pdf
28. Pearson, C. R., Micek, M. A., Simoni, J. M., Hoff, P. D., Matediana, E., Martin, D. P., et al. (2007). Randomized control trial of peer-delivered, modified directly observed therapy for HAART in Mozambique. Journal of Acquired Immune Deficiency Syndromes, 46(2), 238-244. doi:10.1097/QAI.0b013e318153f7ba. (Pubitemid 47482621)
29. Phillips, A. N., Leen, C., Wilson, A., Anderson, J., Dunn, D., Schwenk, A., et al. (2007). Risk of extensive virological failure to the three original antiretroviral drug classes over long-term follow-up from the start of therapy in patients with HIV infection: An observational cohort study. Lancet, 370(9603), 1923-1928. doi:10.1016/S0140-6736(07)61815-7. (Pubitemid 350193334)
30. Population Reference Bureau. (2006). 2006 World population data sheet. 2006, Available from http://www.prb.org/pdf06/06WorldData Sheet.pdf.
31. Rosen, S., Fox, M. P., & Gill, C. J. (2007). Patient retention in antiretroviral therapy programs in sub-Saharan Africa: A systematic review. PLoS Medicine, 4(10), e298. doi: 10.1371/journal.pmed.0040298. (Pubitemid 350035458)
32. Sarna, A., Luchters, S., Geibel, S., Chersich, M. F., Munyao, P., Kaai, S., et al. (2008). Short-and long-term efficacy of modified directly observed antiretroviral treatment in Mombasa, Kenya: A randomized trial. Journal of Acquired Immune Deficiency Syndromes, 48(5), 611-619.
33. Schafer, J. (1997). Analysis of incomplete multivariate data. New York: Chapman and Hall.
34. Semba, R. D., Caiaffa, W. T., Graham, N. M., Cohn, S., & Vlahov, D. (1995). Vitamin A deficiency and wasting as predictors of mortality in human immunodeficiency virus-infected injection drug users. The Journal of Infectious Diseases, 171(5), 1196-1202.
35. Shin, S., Munoz, M., Espiritu, B., Zeladita, J., Sanchez, E., Callacna, M., et al. (2008). Psychosocial impact of poverty on antiretro-viral nonadherence among HIV-TB coinfected patients in Lima, Peru. Journal of the International Association of Physicians in AIDS Care, 7(2), 74-81. doi:10.1177/1545109708315326.
36. Shively, M., Smith, T., Bormann, J., & Gifford, A. (2002). Evaluating self-efficacy for HIV disease management skills. AIDS and Behavior, 6, 371-379. doi:10.1023/A:1021156914683. (Pubitemid 36033599)
37. Simoni, J. M., Pearson, C. R., Pantalone, D. W., Marks, G., & Crepaz, N. (2006). Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load. A meta-analytic review of randomized controlled trials. Journal of Acquired Immune Deficiency Syndromes, 43(Suppl. 1), S23-S35. doi:10.1097/01.qai.0000248342.05438.52. (Pubitemid 44885639)
38. Smith, S. R., Rublein, J. C., Marcus, C., Brock, T. P., & Chesney, M. A. (2003). A medication self-management program to improve adherence to HIV therapy regimens. Patient Education and Counseling, 50(2), 187-199.
39. Spacek, L. A., Shihab, H. M., Kamya, M. R., Mwesigire, D., Ronald, A., Mayanja, H., et al. (2006). Response to antiretroviral therapy in HIV-infected patients attending a public, urban clinic in Kampala, Uganda. Clinical Infectious Diseases, 42(2), 252-259. doi:10.1086/499044. (Pubitemid 43054199)
40. Tuboi, S.H., Harrison, L.H., Sprinz, E., Albernaz, R.K., & Schechter, M. (2005). Predictors of virologic failure in HIV-1-infected patients starting highly active antiretroviral therapy in Porto Alegre, Brazil. Journal of Acquired Immune Deficiency Syndromes, 40(3), 324-328. doi:10.1097/01.qai. 0000182627.28595.01. (Pubitemid 41533073)
41. Van Der Ven, N. C., Weinger, K., Yi, J., Pouwer, F., Ader, H., Van Der Ploeg, H. M., et al. (2003). The confidence in diabetes self-care scale: psychometric properties of a new measure of diabetes-specific self-efficacy in Dutch and US patients with type 1 diabetes. Diabetes Care, 26(3), 713-718. doi: 10.2337/diacare.26.3.713. (Pubitemid 36929333)
42. van Oosterhout, J. J., Bodasing, N., Kumwenda, J. J., Nyirenda, C., Mallewa, J., Cleary, P. R., et al. (2005). Evaluation of antiretroviral therapy results in a resource-poor setting in Blantyre, Malawi. Tropical Medicine & International Health, 10(5), 464-470. doi:10.1111/j.1365-3156.2005.01409.x. (Pubitemid 40712431)
43. Wainberg, M. A., & Friedland, G. (1998). Public health implications of antiretroviral therapy and HIV drug resistance. Journal of the American Medical Association, 279(24), 1977-1983. doi: 10.1001/jama.279.24.1977. (Pubitemid 28298277)
44. Wakabi, W.(2008). Low ART adherenceinAfrica. The LancetInfectious Diseases, 8(2), 94. doi:10.1016/S1473-3099(08)70010-0
45. World Health Organization. (2003). Scaling up antiretroviral therapy in resource-limited settings: Treatment guidelines for a public health approach. Available from http://www.who.int/3by5/publications/ documents/arv-guidelines/ en/.
46. Wu, A. W., Rubin, H. R., Mathews, W. C., Ware, J. E., Jr, Brysk, L. T., Hardy, W. D., et al. (1991). A health status questionnaire using 30 items from the medical outcomes study. Preliminary validation in persons with early HIV infection. Medical Care, 29(8), 786-798. doi:10.1097/00005650-199108000-00011.